B7-H4 expression is associated with cancer progression and predicts patient survival in human thyroid cancer

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 5, 2013, Pages 3011-3015

  Zhu, Jian ^a   Chu, Bing Feng ^a   Yang, Yi Peng ^a   Zhang, Sheng Lai ^a   Zhuang, Ming ^a   Lu, Wen Jie ^a   Liu, Ying Bin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

B7 H4; Prognosis; Progression; Thyroid cancer; Tumor infiltrating lymphocytes

Indexed keywords

MESSENGER RNA; TUMOR MARKER; V SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1; VTCN1 PROTEIN, HUMAN;

ARTICLE; CANCER STAGING; CASE CONTROL STUDY; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; GENETICS; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; THYROID GLAND; THYROID TUMOR;

CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1;

EID: 84880344778     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.5.3011     Document Type: Article

References (22)

1. Abadi YM, Jeon H, Ohaegbulam KC, et al (2013). Host b7x promotes pulmonary metastasis of breast cancer. J Immunol, 190, 3806-14.
2. Arigami T, Uenosono Y, Hirata M, et al (2010). Expression of B7-H4 in blood of patients with gastric cancer predicts tumor progression and prognosis. J Surg Oncol, 102, 748-52.
3. Arigami T, Uenosono Y, Ishigami S, et al (2011). Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer. World J Surg, 35, 2051-7.
4. Awadallah NS, Shroyer KR, Langer DA, et al (2008). Detection of B7-H4 and p53 in pancreatic cancer: potential role as a cytological diagnostic adjunct. Pancreas, 36, 200-6.
5. Chen L (2004). Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol, 4, 336-47.
6. Chen LJ, Sun J, Wu HY, et al (2011). B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma. Cancer Immunol Immunother, 60, 1047-55.
7. Flies DB, Chen L (2007). The new B7s: playing a pivotal role in tumor immunity. J Immunother, 30, 251-60.
8. Grabenbauer GG, Lahmer G, Distel L, et al (2006). Tumorinfiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma. Clin Cancer Res, 12, 3355-60.
9. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
10. Miyatake T, Tringler B, Liu W, et al (2007). B7-H4 (DDO110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration. Gynecol Oncol, 106, 119-27.
11. Oikonomopoulou K, Li L, Zheng Y, et al (2008). Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel. Br J Cancer, 99, 1103-13.
12. Prasad DV, Richards S, Mai XM, et al (2003). B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity, 18, 863-73.
13. Sica GL, Choi IH, Zhu G, et al (2003). B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity, 18, 849-61.
14. Siegel R, Naishadham D & Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.
15. Sun SQ, Jiang CG, Lin Y, et al (2012). Enhanced T cell immunity by B7-H4 downregulation in nonsmall-cell lung cancer cell lines. J Int Med Res, 40, 497-506.
16. Tringler B, Zhuo S, Pilkington G, et al (2005). B7-h4 is highly expressed in ductal and lobular breast cancer. Clin Cancer Res, 11, 1842-8.
17. Tuttle RM, Ball DW, Byrd D, et al (2010). Thyroid carcinoma. J Natl Compr Canc Netw, 8, 1228-74.
18. Xie WC, Chan MH, Mak KC, et al (2012). Trends in the incidence of 15 common cancers in Hong Kong, 1983-2008. Asian Pac J Cancer Prev, 13, 3911-6.
19. Xing M (2013). Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer, 13, 184-99.
20. Zang X, Loke P, Kim J, et al (2003). B7x: a widely expressed B7 family member that inhibits T cell activation. Proc Natl Acad Sci U S A, 100, 10388-92.
21. Zhang L, Wu H, Lu D, et al (2013). The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus. Oncogene, Jan 14. doi: 10.1038/onc.2012.600. [Epub ahead of print].
22. Zheng X, Li XD, Wu CP, et al (2012). Expression of costimulatory molecule B7-H4 in human malignant tumors. Onkologie, 35, 700-5.